Identification of A3 receptor- and mast cell-dependent and -independent components of adenosine-mediated airway responsiveness in mice

Journal of Immunology

Volumn 171, Issue 1, 2003, Pages 331-337

  Tilley, Stephen L ^a   Tsai, Mindy ^a   Williams, Cara M ^a   Wang, Z S ^a   Erikson, Christopher J ^a   Galli, Stephen J ^a   Koller, Beverly H ^a,b,c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSINE A3 RECEPTOR; G PROTEIN COUPLED RECEPTOR; SODIUM CHLORIDE; ADENOSINE RECEPTOR;

AEROSOL; ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; EXPOSURE; FEMALE; HISTOLOGY; MALE; MAST CELL; MAST CELL DEGRANULATION; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; DEGRANULATION; DOWN REGULATION; GENETICS; INFLAMMATION; INHALATIONAL DRUG ADMINISTRATION; LUNG; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; UPREGULATION;

ADENOSINE; ADMINISTRATION, INHALATION; AEROSOLS; ANIMALS; BRONCHIAL HYPERREACTIVITY; CELL DEGRANULATION; DOWN-REGULATION; INFLAMMATION; LUNG; MAST CELLS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, MUTANT STRAINS; NEUTROPHIL INFILTRATION; RECEPTOR, ADENOSINE A3; RECEPTORS, PURINERGIC P1; UP-REGULATION;

EID: 0038375944     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.1.331     Document Type: Article

References (57)

1. Fredholm, B. B., A. P. IJzerman, K. A. Jacobson, K. N. Klotz, and J. Linden. 2001. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol. Rev. 53:527.
2. Marquardt, D. L., H. E. Gruber, and S. I. Wasserman. 1984. Adenosine release from stimulated mast cells. Proc. Natl. Acad. Sci. USA 81:6192.
3. Zimmermann, H. 2000. Extracellular metabolism of ATP and other nucleotides. Naunyn Schmiedebergs Arch. Pharmacol. 362:299.
4. Mubagwa, K., and W. Flameng. 2001. Adenosine, adenosine receptors and myocardial protection: an updated overview. Cardiovasc. Res. 52:25.
5. 3 adenosine receptor as a target for cancer therapy. Anticancer Drugs 13:437.
6. Jacobson, M. A., and T. R. Bai. 1997. The role of adenosine in asthma. In Purinergic Approaches in Experimental Therapeutics. K. A. Jacobson and M. F. Jarvis, eds. Wiley-Liss, New York, pp. 315-331.
7. Rutgers, S. R., W. Timens, N. Tzanakis, H. F. Kauffman, T. W. van der Mark, G. H. Koeter, and D. S. Postma. 2000. Airway inflammation and hyperresponsiveness to adenosine 5′-monophosphate in chronic obstructive pulmonary disease. Clin. Exp. Allergy 30:657.
8. Meade, C. J., I. Dumont, and L. Worrall. 2001. Why do asthmatic subjects respond so strongly to inhaled adenosine? Life Sci. 69:1225.
9. Cushley, M. J., A. E. Tattersfield, and S. T. Holgate. 1983. Inhaled adenosine and guanosine on airway resistance in normal and asthmatic subjects. Br. J. Clin. Pharmacol. 15:161.
10. 20 of methacholine. Am. J. Respir. Crit. Care Med. 164:1127.
11. 3 receptors mediate rapid inflammatory cell influx into the lungs of sensitized guinea-pigs. Clin. Exp. Allergy 31:943.
12. Fan, M., and S. J. Mustafa. 2002. Adenosine-mediated bronchoconstriction and lung inflammation in an allergic mouse model. Pulm. Pharmacol. Ther. 15:147
13. Blackburn, M. R., J. B. Volmer, J. L. Thrasher, H. Zhong, J. R. Crosby, J. J. Lee, and R. E. Kellems. 2000. Metabolic consequences of adenosine deaminase deficiency in mice are associated with defects in alveogenesis, pulmonary inflammation, and airway obstruction. J. Exp. Med. 192:159.
14. Driver, A. G., C. A. Kukoly, S. Ali, and S. J. Mustafa. 1993. Adenosine in bronchoalveolar lavage fluid in asthma. Am. Rev. Respir. Dis. 148:91.
15. Forsythe, P., and M. Ennis. 1999. Adenosine, mast cells and asthma. Inflamm. Res. 48:301.
16. Fozard, J. R., and J. P. Hannon. 2000. Species differences in adenosine receptor-mediated bronchoconstrictor responses. Clin. Exp. Allergy 30:1213.
17. 1 receptor. J. Pharmacol. Exp. Ther. 268:1328.
18. Polosa, R., W. H. Ng, N. Crimi, C. Vancheri, S. T. Holgate, M. K. Church, and A. Mistretta. 1995. Release of mast-cell-derived mediators after endobronchial adenosine challenge in asthma. Am. J. Respir. Crit. Care Med. 151:624.
19. Phillips, G. D., P. Rafferty, R. Beasley, and S. T. Holgate. 1987. Effect of oral terfenadine on the bronchoconstrictor response to inhaled histamine and adenosine 5′-monophosphate in non-atopic asthma. Thorax 42:939.
20. Pauwels, R. A., and M. E. Van der Straeten. 1987. An animal model for adenosine-induced bronchoconstriction. Am. Rev. Respir. Dis. 136:374.
21. Hannon, J. P., B. Tigani, I. Williams, L. Mazzoni, and J. R. Fozard. 2001. Mechanism of airway hyperresponsiveness to adenosine induced by allergen challenge in actively sensitized Brown Norway rats. Br. J. Pharmacol. 132:1509.
22. el Hashim, A., B. D'Agostino, M. G. Matera, and C. Page. 1996. Characterization of adenosine receptors involved in adenosine-induced bronchoconstriction in allergic rabbits. Br. J. Pharmacol. 119:1262.
23. 3 generation in allergic rabbit airway smooth muscle. Am. J. Physiol 275:L990.
24. Nyce, J. W., and W. J. Metzger. 1997. DNA antisense therapy for asthma in an animal model. Nature 385:721.
25. 2b receptors evoke interleukin-8 secretion in human mast cells: an enprofylline-sensitive mechanism with implications for asthma. J. Clin. Invest 96:1979.
26. 2b adenosine receptors: radioligand binding, western blotting, and coupling to Gq in human embryonic kidney 293 cells and HMC-1 mast cells. Mol. Pharmacol. 56:705.
27. 2b receptor. Mol. Pharmacol. 52:846.
28. 3 receptor activation in rats. Eur. J. Pharmacol. 298:293.
29. 3 receptors promote degranulation of rat mast cells both in vitro and in vivo. Inflamm. Res. 46:180.
30. 3 receptors on mast cells. J. Clin. Invest 105:361.
31. Galli, S. J., and Y. Kitamura. 1987. Genetically mast-cell-deficient W/Wv and S1/S1d mice. Their value for the analysis of the roles of mast cells in biologic responses in vivo. Am. J. Pathol. 127:191.
32. 3 adenosine receptor gene in mice and its effect on stimulated inflammatory cells. J. Biol. Chem. 275:4429.
33. Hamelmann, E., J. Schwarze, K. Takeda, A. Oshiba, G. L. Larsen, C. G. Irvin, and E. W. Gelfand. 1997. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am. J. Respir. Crit. Care Med. 156:766.
34. Wershil, B. K., T. Murakami, and S. J. Galli. 1988. Mast cell-dependent amplification of an immunologically nonspecific inflammatory response. Mast cells are required for the full expression of cutaneous acute inflammation induced by phorbol 12-myristate 13-acetate. J. Immunol. 140:2356.
35. Martin, T. R., S. J. Galli, I. M. Katona, and J. M. Drazen. 1989. Role of mast cells in anaphylaxis: evidence for the importance of most cells in the cardiopulmonary alterations and death induced by anti-IgE in mice. J. Clin. Invest. 83:1375.
36. Wershil, B. K., Z. S. Wang, J. R. Gordon, and S. J. Galli. 1991. Recruitment of neutrophils during IgE-dependent cutaneous late phase reactions in the mouse is mast cell-dependent: partial inhibition of the reaction with antiserum against tumor necrosis factor-α. J. Clin. Invest 87:446.
37. Biedermann, T., M. Kneilling, R. Mailhammer, K. Maier, C. A. Sander, G. Kollias, S. L. Kunkel, L. Hultner, and M. Rocken. 2000. Mast cells control neutrophil recruitment during T cell-mediated delayed-type hypersensitivity reactions through tumor necrosis factor and macrophage inflammatory protein 2. J. Exp. Med. 192:1441.
38. Williams, C. M., and S. J. Galli. 2000. The diverse potential effector and immunoregulatory roles of mast cells in allergic disease. J. Allergy Clin. Immunol. 105:847.
39. Forsythe, P., L. P. McGarvey, L. G. Heaney, J. MacMahon, and M. Ennis. 1999. Adenosine induces histamine release from human bronchoalveolar lavage mast cells. Clin. Sci. 96:349.
40. Church, M. K., and P. J. Hughes. 1985. Adenosine potentiates immunological histamine release from rat mast cells by a novel cyclic AMP-independent cell-surface action. Br. J. Pharmacol. 85:3.
41. Peachell, P. T., M. Columbo, A. Kagey-Sobotka, L. M. Lichtenstein, and G. Marone. 1988. Adenosine potentiates mediator release from human lung mast cells. Am. Rev. Respir. Dis. 138:1143.
42. 3 receptor. J. Immunol. 170:0000.
43. Martin, T. R., T. Takeishi, H. R. Katz, K. F. Austen, J. M. Drazen, and S. J. Galli. 1993. Mast cell activation enhances airway responsiveness to methacholine in the mouse. J. Clin. Invest 91:1176.
44. Bjorck, T., L. E. Gustafsson, and S. E. Dahlen. 1992. Isolated bronchi from asthmatics are hyperresponsive to adenosine, which apparently acts indirectly by liberation of leukotrienes and histamine. Am. Rev. Respir. Dis. 145:1087.
45. Phillips, G. D., V. L. Scott, R. Richards, and S. T. Holgate. 1989. Effect of nedocromil sodium and sodium cromoglycate against bronchoconstriction induced by inhaled adenosine 5′-monophosphate. Eur. Respir. J. 2:210.
46. Brightling, C. E., P. Bradding, F. A. Symon, S. T. Holgate, A. J. Wardlaw, and I. D. Pavord. 2002. Mast-cell infiltration of airway smooth muscle in asthma. N. Engl. J. Med. 346:1699.
47. 3 receptor expression in normal and asthmatic lung. Drug Dev. Res. 31:244.
48. Wenzel, S. E., S. J. Szefler, D. Y. Leung, S. I. Sloan, M. D. Rex, and R. J. Martin. 1997. Bronchoscopic evaluation of severe asthma: persistent inflammation associated with high dose glucocorticoids. Am. J. Respir. Crit. Care Med. 156:737.
49. Carroll, N., S. Carello, C. Cooke, and A. James. 1996. Airway structure and inflammatory cells in fatal attacks of asthma. Eur. Respir. J. 9:709.
50. Mundell, S. J., M. E. Olah, R. A. Panettieri, J. L. Benovic, and R. B. Penn. 2001. Regulation of G protein-coupled receptor-adenylyl cyclase responsiveness in human airway smooth muscle by exogenous and autocrine adenosine. Am. J. Respir. Cell Mol. Biol. 24:155.
51. Nilsen, D., R. Hirschhom, B. Cronstein, A. Talbot, C. Aston, and J. Reibman. 1995. Expression of adensoine receptors in human alveolar macrophages and airway epithelial cell. Am. J. Respir. Crit. Care Med. 151: A190.
52. Okayama, M., J.-Y. Ma, I. Hataoka, K. Kimura, M. Miura, H. Ijima, H. Inoue, and T. Takashima. 1986. Role of vagal nerve activity on adenosine-induced bronchoconstriction in asthma. Am. Rev. Respir. Dis. 133:A93.
53. Crimi, N., F. Palermo, R. Oliveri, R. Polosa, I. Settinieri, and A. Mistretta. 1992. Protective effects of inhaled ipratropium bromide on bronchoconstriction induced by adenosine and methacholine in asthma. Eur. Respir. J. 5:560.
54. Polosa, R., G. D. Phillips, K. Rajakulasingam, and S. T. Holgate. 1991. The effect of inhaled ipratropium bromide alone and in combination with oral terfenadine on bronchoconstriction provoked by adenosine 5′-monophosphate and histamine in asthma. J. Allergy Clin. Immunol. 87:939.
55. 3 receptor expression and function in eosinophils. Am. J. Respir. Cell Mol. Biol. 16:531.
56. 3 receptor expression in normal and asthmatic lung. Drug Dev. Res. 31:244.
57. Yano, K., M. Yamaguchi, F. de Mora, C. S. Lantz, J. H. Butterfield, J. J. Costa, and S. J. Galli. 1997. Production of macrophage inflammatory protein-la by human mast cells: Increased anti-IgE-dependent secretion after IgE-dependent enhancement of mast cell IgE-binding ability. Lab. Invest. 77:185.